cs.DLMay 10, 2026

The Biosecurity Blind Spot: Systematic Dual-use Detection in Open Science Infrastructure

Authors: Vasudha Sharma, Chakresh Kumar Singh, Jayesh Choudhari, Dharmit Nakrani

Organizations: 1LophiLabs · 2Independent.

Abstract

AI is transforming life sciences research at unprecedented speed, accelerating discovery across protein structure prediction, genome modeling, and drug development (Jumper et al., 2021; Mak et al., 2024). Yet this rapid advancement, coupled with the open science movement, introduces significant dual-use research concerns that have received limited empirical scrutiny. Here we present the first systematic analysis of dual-use research of concern (DURC) content on open preprint servers. We screened ~52,000 bioRxiv preprints (2024-2025) using a hybrid pipeline of lexical filtering and large language model (LLM) evaluation, scoring metadata across nine DURC, three PEPP, and five governance categories aligned with U.S. and Australia Group oversight frameworks. Our analysis reveals that dual-use-adjacent knowledge is routinely present in openly accessible titles and abstracts, often exceeding established risk thresholds even in studies with legitimate public health objectives. While this mapping captures surface-level information diffusion, it does not measure operational capability, downstream misuse potential, or the substantial technical and biosafety barriers that constrain harmful application. We argue that institutional review processes, funding requirements, and preprint platform policies must evolve to incorporate proactive, metadata-level monitoring without compromising scientific transparency. Ultimately, harmonizing controlled-access mechanisms for high-risk methodologies with open summaries of scientific contributions offers a pragmatic framework for governing AI-accelerated biology at scale.

Explore similar work

Jul 6, 2026cs.CR

Evaluating calibrated refusal and safe usefulness in dual-use biology settings

As AI agents are incorporated into life science workflows, the capabilities that speed discovery might also enable misuse. We present BioSecBench-Refusal, a benchmark for risk identification and refusal behavior for biological research tasks. The benchmark pairs 61 Routine tasks, legitimate analyses adapted from the published literature, with 46 Red-Team tasks, fictional scenarios that resemble real research but conceal a biosecurity hazard. Across 16 model-harness configurations, refusal rates ranged from 7% to 74% on Routine tasks and 1% to 62% on Red-Team tasks, with many configurations refusing legitimate Routine work at comparable or higher rates than concealed hazards. Refusals were most often triggered by provider API filters applied prior to agentic reasoning. However, models given room to reason showed the potential to identify more real threats. We release BioSecBench-Refusal as a tool for model developers to calibrate capability and caution for agentic biotech R&D.
Edwin H. Wintermute, Harmon Bhasin, Christina M. Agapakis +13
Jun 9, 2026cs.AI

ABC-Bench: An Agentic Bio-Capabilities Benchmark for Biosecurity

Large language models (LLMs) are rapidly acquiring capabilities relevant to biological research, from literature synthesis to interpretation of experimental data. Increasingly, LLM agents can also perform in silico biology tasks that previously required experienced human biologists. These emerging AI capabilities offer new opportunities for scientific discovery and biomedical advances, but they also shift the landscape of biosecurity risks. To address this, we introduce the Agentic Bio-Capabilities Benchmark (ABC-Bench), a suite of tasks to measure agentic biosecurity-relevant capabilities. ABC-Bench evaluates LLM agents on both benign and dual-use biology tasks: writing code to operate liquid handling robots, designing DNA fragments for in vitro assembly, and evading DNA synthesis screening. These tasks require a combination of biology and software expertise. All tested LLM agents outperformed the median expert human baseliner on all three tasks. Agents performed highly on tasks drawing on published knowledge and well-documented protocols, and more weakly on a task requiring novel bioinformatics reasoning. In three wet-lab validation experiments, we found that OpenAI's o4-mini-high produced scripts that, when run on an OpenTrons liquid handling robot, successfully assembled DNA with expected sequences.
Andrew Bo Liu, Samira Nedungadi, Bryce Cai +3
Jul 7, 2026cs.DL

AAAI-26 Dual Submissions: Novel Challenges

Dual submissions, in which identical or substantially similar papers are simultaneously submitted to one or more archival venues, without cross-citation or disclosure, are a growing problem for the AAAI Conference and other scientific publication venues. These submissions increase the burden on the peer-review system and pollute the scientific record. As part of the AAAI-26 review process, we (conference organizers) compared AAAI main-track submissions to nine other archival venues with overlapping review periods. We also searched for dual submissions within the AAAI-26 main track. We employed title+abstract similarity assessment to prioritize highly similar paper pairs for subsequent triage by an LLM-based overlap assessment tool, followed by manual review of the highest severity pairs. Manual review of such pairs led to the desk-rejection of 141 AAAI-26 main-track submissions. We seek to alert future organizers, and the broader artificial intelligence research community, to the enormous growth in dual submissions. The incidence of exact duplicate submissions, which are easy to detect, has been eclipsed by the number of papers that use different words to describe the same contribution, which are extremely time-consuming to detect. The growth in this phenomenon is likely facilitated by increasing access to generative AI tools. We include several recommendations for addressing this challenge, including (1) updating the AAAI Multiple Submission Policy and educating the community about acceptable practice, (2) having dual-submission checking tools in place before submissions close, (3) working across venues to converge on consistent policies and penalties to aid in reducing the incidence of dual submission, and (4) creating a community-driven adversarial challenge to accelerate the development of robust detection tools.
Kiri L. Wagstaff, Joydeep Biswas, Erich Merrill +4